Home » Posts tagged with » United Kingdom
Recipharm to acquire British CDMO Consort Medical for £505m

Recipharm to acquire British CDMO Consort Medical for £505m

Recipharm acquisition of Consort Medical : Swedish pharma group Recipharm has agreed to acquire Consort Medical, a British contract development and manufacturing organization (CDMO) for £505 million, as per the latest pharma acquisition news. The transaction is said to help Recipharm become a major inhalation company and places it among the top five CDMO players […]

Innovia Medical acquires surgical instruments manufacturer DTR Medical

Innovia acquisition of DTR Medical : Medical devices manufacturer Innovia Medical has acquired Wales-based DTR Medical, which designs and manufactures single-use surgical instruments for general and specialist surgical procedures. Financial terms of the deal were not disclosed. Established in 2005, DTR Medical started selling its own-branded sterile single-use instruments. In 2007, the Swansea-based surgical instruments […]

Continue reading …
Researchers develop new AI-driven model for drug discovery

Researchers at the University of Cambridge have developed a new artificial intelligence (AI) algorithm, which can predict the complex chemical reactions outcomes with more than 90% accuracy and facilitate the drug discovery by suggesting ways to make complex molecules. Providing the chemical ‘map’ to the desired destination, the new algorithm also shows chemists how to […]

Continue reading …
Boston Scientific wraps up $4.2bn acquisition of BTG

Boston Scientific acquisition of BTG : US medical devices manufacturer Boston Scientific has wrapped up its previously announced $4.2 billion acquisition of UK-based healthcare company BTG. In November 2018, Boston Scientific reached an agreement on the terms of a recommended offer to acquire the British healthcare company for a cash consideration of 840 pence per […]

Continue reading …
Laboratory-grown red blood cells could help study malaria invasion, say researchers

Scientists at the University of Bristol and Imperial College London, UK, have developed a new research system to study how malaria parasites invade red blood cells using laboratory-grown red blood cells. Funded by the National Institute for Health Research (NIHR) and NHS Blood and Transplant, the new tool will identify key host proteins and their domains involved in […]

Continue reading …
Mereo BioPharma begins BPS-804 mid-stage trial in osteogenesis imperfecta

British specialty biopharma company Mereo BioPharma Group has wrapped up enrollment of patients for a phase 2b clinical trial that will evaluate its human monoclonal antibody BPS-804 (Setrusumab) as a potential treatment option for osteogenesis imperfecta (OI), better known as the brittle bone disease. Osteogenesis imperfecta is a rare, chronic genetic disorder that makes bones […]

Continue reading …
Evox Therapeutics raises £35.5m to advance exosome therapeutics

Evox Therapeutics, an Oxford biotech spinout focused on developing exosome therapeutics, has raised £35.5 million from a Series B financing round led by Redmile Group with new investments from Google’s GV, Cowen Healthcare Investments and others. The Series B round of the UK biotechnology company also saw participation from existing investors – Oxford Sciences Innovation […]

Continue reading …
Gene therapy company Orchard Therapeutics raises $150m in new funding

Orchard Therapeutics, a UK and US based gene therapy company, has secured $150 million of new capital through a Series C funding round, towards advancing its gene therapies for rare diseases. Deerfield Management led the Series C round with other firms like RA Capital Management, Perceptive Advisors, Venrock and Foresite Capital making new investments in […]

Continue reading …
Britannia Pharmaceuticals apomorphine infusion succeeds in TOLEDO trial

Phase 3 trial for apomorphine infusion : British pharma company Britannia Pharmaceuticals said that its APO-go/MOVAPO (apomorphine) subcutaneous infusion has succeeded in a phase 3 trial called TOLEDO by delivering effective relief of persistent motor fluctuations in Parkinson’s disease. The TOLEDO trial saw apomorphine infusion given for 12 weeks in 107 Parkinson’s disease patients whose […]

Continue reading …
CHMP recommends AstraZeneca lung cancer drug Imfinzi EMA approval

Update on Imfinzi EMA approval : The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the approval of AstraZeneca lung cancer drug Imfinzi (durvalumab) for the treatment of locally-advanced, unresectable non-small cell lung cancer (NSCLC). The committee has recommended Imfinzi EMA approval of […]

Continue reading …